| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Trends in the aggressiveness of cancer care near the end of life.
|
J Clin Oncol
|
2004
|
7.45
|
|
2
|
Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium.
|
J Clin Oncol
|
2004
|
7.02
|
|
3
|
Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?
|
J Clin Oncol
|
2008
|
5.61
|
|
4
|
Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review.
|
Lancet
|
2004
|
4.99
|
|
5
|
Identifying potential indicators of the quality of end-of-life cancer care from administrative data.
|
J Clin Oncol
|
2003
|
4.50
|
|
6
|
Quality of non-breast cancer health maintenance among elderly breast cancer survivors.
|
J Clin Oncol
|
2003
|
4.24
|
|
7
|
Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study.
|
BMJ
|
2014
|
3.90
|
|
8
|
Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions.
|
J Natl Cancer Inst
|
2012
|
3.16
|
|
9
|
Impact of referral patterns on the use of chemotherapy for lung cancer.
|
J Clin Oncol
|
2002
|
3.09
|
|
10
|
End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences.
|
J Clin Oncol
|
2010
|
2.97
|
|
11
|
Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer.
|
JAMA
|
2010
|
2.93
|
|
12
|
Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study.
|
J Clin Oncol
|
2013
|
2.91
|
|
13
|
Cost-effectiveness of computed tomography screening for lung cancer in the United States.
|
J Thorac Oncol
|
2011
|
2.83
|
|
14
|
HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis.
|
J Clin Oncol
|
2004
|
2.78
|
|
15
|
Evaluating claims-based indicators of the intensity of end-of-life cancer care.
|
Int J Qual Health Care
|
2005
|
2.75
|
|
16
|
Views of American oncologists about the purposes of clinical trials.
|
J Natl Cancer Inst
|
2002
|
2.71
|
|
17
|
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures.
|
J Clin Oncol
|
2008
|
2.69
|
|
18
|
Physicians' attitudes about multiplex tumor genomic testing.
|
J Clin Oncol
|
2014
|
2.62
|
|
19
|
Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer.
|
JAMA
|
2012
|
2.56
|
|
20
|
Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.
|
J Natl Cancer Inst
|
2008
|
2.56
|
|
21
|
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.
|
J Clin Oncol
|
2012
|
2.53
|
|
22
|
Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.
|
J Clin Oncol
|
2005
|
2.52
|
|
23
|
Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).
|
J Clin Oncol
|
2005
|
2.48
|
|
24
|
Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study.
|
Radiology
|
2008
|
2.37
|
|
25
|
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344).
|
J Natl Cancer Inst
|
2006
|
2.34
|
|
26
|
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
|
J Clin Oncol
|
2006
|
2.29
|
|
27
|
A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network.
|
Ann Surg
|
2006
|
2.29
|
|
28
|
Representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program.
|
Med Care
|
2013
|
2.22
|
|
29
|
Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium.
|
J Clin Oncol
|
2010
|
2.16
|
|
30
|
Parents' views of cancer-directed therapy for children with no realistic chance for cure.
|
J Clin Oncol
|
2008
|
2.12
|
|
31
|
Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers.
|
J Natl Cancer Inst
|
2003
|
2.11
|
|
32
|
End-of-life care discussions among patients with advanced cancer: a cohort study.
|
Ann Intern Med
|
2012
|
2.08
|
|
33
|
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study.
|
J Clin Oncol
|
2012
|
1.95
|
|
34
|
Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer.
|
J Clin Oncol
|
2009
|
1.94
|
|
35
|
Treatment decision making in early-stage breast cancer: should surgeons match patients' desired level of involvement?
|
J Clin Oncol
|
2002
|
1.89
|
|
36
|
Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis.
|
BMJ
|
2010
|
1.87
|
|
37
|
Site of oncologic specialty care for older adolescents in Utah.
|
J Clin Oncol
|
2007
|
1.87
|
|
38
|
Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles?
|
J Clin Oncol
|
2010
|
1.84
|
|
39
|
Parent and physician perspectives on quality of care at the end of life in children with cancer.
|
J Clin Oncol
|
2005
|
1.78
|
|
40
|
Discussions with physicians about hospice among patients with metastatic lung cancer.
|
Arch Intern Med
|
2009
|
1.77
|
|
41
|
Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.
|
Cancer
|
2012
|
1.75
|
|
42
|
Hope and prognostic disclosure.
|
J Clin Oncol
|
2007
|
1.73
|
|
43
|
Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes.
|
J Natl Cancer Inst
|
2011
|
1.71
|
|
44
|
Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
|
J Natl Cancer Inst
|
2005
|
1.70
|
|
45
|
Selecting high priority quality measures for breast cancer quality improvement.
|
Med Care
|
2008
|
1.70
|
|
46
|
Medical oncologists' perceptions of financial incentives in cancer care.
|
J Clin Oncol
|
2012
|
1.69
|
|
47
|
Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information.
|
J Clin Oncol
|
2006
|
1.66
|
|
48
|
High-cost imaging in elderly patients with stage IV cancer.
|
J Natl Cancer Inst
|
2012
|
1.63
|
|
49
|
Improving the care of children with advanced cancer by using an electronic patient-reported feedback intervention: results from the PediQUEST randomized controlled trial.
|
J Clin Oncol
|
2014
|
1.63
|
|
50
|
Peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the partnership for health study.
|
J Clin Oncol
|
2005
|
1.61
|
|
51
|
Understanding of prognosis among parents of children with cancer: parental optimism and the parent-physician interaction.
|
J Clin Oncol
|
2007
|
1.56
|
|
52
|
Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases.
|
J Clin Oncol
|
2002
|
1.55
|
|
53
|
Quality of health care for children: role of health and chronic illness in inpatient care experiences.
|
Arch Pediatr Adolesc Med
|
2007
|
1.53
|
|
54
|
Easing of suffering in children with cancer at the end of life: is care changing?
|
J Clin Oncol
|
2008
|
1.52
|
|
55
|
Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?
|
Med Care
|
2009
|
1.51
|
|
56
|
Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction.
|
J Clin Oncol
|
2002
|
1.49
|
|
57
|
A qualitative study of oncologists' approaches to end-of-life care.
|
J Palliat Med
|
2008
|
1.49
|
|
58
|
Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients.
|
J Clin Oncol
|
2005
|
1.44
|
|
59
|
Considerations about hastening death among parents of children who die of cancer.
|
Arch Pediatr Adolesc Med
|
2010
|
1.44
|
|
60
|
Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness.
|
J Clin Oncol
|
2003
|
1.41
|
|
61
|
Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score.
|
J Clin Oncol
|
2006
|
1.39
|
|
62
|
An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population.
|
Health Econ
|
2003
|
1.34
|
|
63
|
Looking beyond where children die: determinants and effects of planning a child's location of death.
|
J Pain Symptom Manage
|
2008
|
1.33
|
|
64
|
Do variations in provider discussions explain socioeconomic disparities in postmastectomy breast reconstruction?
|
J Am Coll Surg
|
2008
|
1.31
|
|
65
|
Receipt of appropriate surgical care for Medicare beneficiaries with cancer.
|
Arch Surg
|
2011
|
1.31
|
|
66
|
Expectations about the effectiveness of radiation therapy among patients with incurable lung cancer.
|
J Clin Oncol
|
2013
|
1.30
|
|
67
|
The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer.
|
Cancer
|
2010
|
1.30
|
|
68
|
Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients.
|
J Clin Oncol
|
2007
|
1.29
|
|
69
|
Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment.
|
J Clin Oncol
|
2009
|
1.28
|
|
70
|
Institutional variation in the surgical treatment of breast cancer: a study of the NCCN.
|
Ann Surg
|
2011
|
1.28
|
|
71
|
Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period.
|
Cancer
|
2008
|
1.26
|
|
72
|
Treatment of early stage breast cancer: do surgeons and patients agree regarding whether treatment alternatives were discussed?
|
Breast Cancer Res Treat
|
2003
|
1.26
|
|
73
|
Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study.
|
Breast Cancer Res
|
2012
|
1.26
|
|
74
|
Direct-to-consumer advertising in oncology: a content analysis of print media.
|
J Clin Oncol
|
2007
|
1.25
|
|
75
|
Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.25
|
|
76
|
Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts.
|
Med Care
|
2014
|
1.24
|
|
77
|
Incremental treatment costs in national cancer institute-sponsored clinical trials.
|
JAMA
|
2003
|
1.22
|
|
78
|
Hospice care and survival among elderly patients with lung cancer.
|
J Palliat Med
|
2011
|
1.22
|
|
79
|
Attitudes of patients with cancer about personalized medicine and somatic genetic testing.
|
J Oncol Pract
|
2012
|
1.21
|
|
80
|
Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
|
J Clin Oncol
|
2004
|
1.20
|
|
81
|
The impact of breast reconstruction on the delivery of chemotherapy.
|
Cancer
|
2010
|
1.20
|
|
82
|
Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
|
J Clin Oncol
|
2007
|
1.18
|
|
83
|
Underuse of hospice care by Medicaid-insured patients with stage IV lung cancer in New York and California.
|
J Clin Oncol
|
2013
|
1.16
|
|
84
|
The effect of age on delay in diagnosis and stage of breast cancer.
|
Oncologist
|
2012
|
1.15
|
|
85
|
Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network.
|
J Clin Oncol
|
2008
|
1.15
|
|
86
|
Altruism among participants in cancer clinical trials.
|
Clin Trials
|
2011
|
1.15
|
|
87
|
Regional variation in spending and survival for older adults with advanced cancer.
|
J Natl Cancer Inst
|
2013
|
1.14
|
|
88
|
When does quality-adjusting life-years matter in cost-effectiveness analysis?
|
Health Econ
|
2004
|
1.14
|
|
89
|
Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis.
|
Med Decis Making
|
2006
|
1.14
|
|
90
|
The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers.
|
J Clin Oncol
|
2006
|
1.13
|
|
91
|
Long-term follow-up and individual item analysis of quality of life assessments related to laparoscopic-assisted colectomy in the COST trial 93-46-53 (INT 0146).
|
Ann Surg Oncol
|
2011
|
1.09
|
|
92
|
Optimistic expectations and survival after hematopoietic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2003
|
1.08
|
|
93
|
Quality-of-life-adjusted survival analysis of high-dose adjuvant interferon alpha-2b for high-risk melanoma patients using intergroup clinical trial data.
|
J Clin Oncol
|
2002
|
1.07
|
|
94
|
Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study.
|
Ann Intern Med
|
2014
|
1.05
|
|
95
|
Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening.
|
Risk Anal
|
2012
|
1.05
|
|
96
|
Enrollment of patients with lung and colorectal cancers onto clinical trials.
|
J Oncol Pract
|
2013
|
1.05
|
|
97
|
Employment among survivors of lung cancer and colorectal cancer.
|
J Clin Oncol
|
2010
|
1.02
|
|
98
|
Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?
|
J Natl Cancer Inst
|
2013
|
1.00
|
|
99
|
Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
|
J Am Coll Surg
|
2008
|
1.00
|
|
100
|
Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.00
|
|
101
|
Unmeasured costs of a child's death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer.
|
J Clin Oncol
|
2011
|
0.98
|
|
102
|
Economic outcomes of breast cancer survivorship: CALGB study 79804.
|
Breast Cancer Res Treat
|
2005
|
0.98
|
|
103
|
Satisfaction of the uncertainty principle in cancer clinical trials: retrospective cohort analysis.
|
BMJ
|
2004
|
0.98
|
|
104
|
Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network.
|
Cancer
|
2012
|
0.97
|
|
105
|
The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
|
Cancer
|
2006
|
0.96
|
|
106
|
Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants.
|
Med Care
|
2008
|
0.96
|
|
107
|
Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort study.
|
Cancer
|
2012
|
0.95
|
|
108
|
Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.95
|
|
109
|
The effect of age, race and gender on preference scores for hypothetical health states.
|
Qual Life Res
|
2006
|
0.95
|
|
110
|
Breast cancer prevention: patient decision making and risk communication in the high risk setting.
|
Breast J
|
2009
|
0.93
|
|
111
|
Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer.
|
J Clin Oncol
|
2008
|
0.93
|
|
112
|
Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancer.
|
J Natl Compr Canc Netw
|
2009
|
0.92
|
|
113
|
Reliability of staging, prognosis, and comorbidity data collection in the National Comprehensive Cancer Network (NCCN) non-Hodgkin lymphoma (NHL) multicenter outcomes database.
|
Cancer
|
2008
|
0.91
|
|
114
|
The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidence.
|
Ann Surg
|
2012
|
0.90
|
|
115
|
Time to diagnosis and breast cancer stage by race/ethnicity.
|
Breast Cancer Res Treat
|
2012
|
0.90
|
|
116
|
Physicians' propensity to discuss prognosis is associated with patients' awareness of prognosis for metastatic cancers.
|
J Palliat Med
|
2014
|
0.89
|
|
117
|
Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer.
|
Oncologist
|
2012
|
0.88
|
|
118
|
Impact of oncology-related direct-to-consumer advertising: association with appropriate and inappropriate prescriptions.
|
Cancer
|
2012
|
0.87
|
|
119
|
A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.
|
Genet Med
|
2002
|
0.87
|
|
120
|
Using economic analysis to evaluate the potential of multimodality therapy for elderly patients with locally advanced pancreatic cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.86
|
|
121
|
The role of families in decisions regarding cancer treatments.
|
Cancer
|
2015
|
0.86
|
|
122
|
Economic evaluation of breast cancer treatment: considering the value of patient choice.
|
J Clin Oncol
|
2003
|
0.86
|
|
123
|
Outcomes of informed consent among parents of children in cancer clinical trials.
|
Pediatr Blood Cancer
|
2011
|
0.85
|
|
124
|
Radiation therapy for ductal carcinoma in situ: a decision analysis.
|
Cancer
|
2011
|
0.85
|
|
125
|
Patient choice of breast cancer treatment: impact on health state preferences.
|
Med Care
|
2002
|
0.85
|
|
126
|
Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.
|
Cancer
|
2012
|
0.85
|
|
127
|
Sequelae of axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma.
|
Cancer
|
2002
|
0.85
|
|
128
|
Medicare breast surgery fees and treatment received by older women with localized breast cancer.
|
Health Serv Res
|
2003
|
0.85
|
|
129
|
Variation in the utilization of reconstruction following mastectomy in elderly women.
|
Ann Surg Oncol
|
2012
|
0.84
|
|
130
|
Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancer.
|
Cancer
|
2013
|
0.83
|
|
131
|
Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information.
|
J Clin Oncol
|
2006
|
0.83
|
|
132
|
Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer.
|
Fertil Steril
|
2012
|
0.83
|
|
133
|
Patient utilities for advanced cancer: effect of current health on values.
|
Med Care
|
2005
|
0.82
|
|
134
|
Parents' roles in decision making for children with cancer in the first year of cancer treatment.
|
J Clin Oncol
|
2011
|
0.82
|
|
135
|
Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study.
|
BMC Cancer
|
2011
|
0.80
|
|
136
|
Long-term risk perceptions of women with ductal carcinoma in situ.
|
Oncologist
|
2013
|
0.80
|
|
137
|
Peace of mind and sense of purpose as core existential issues among parents of children with cancer.
|
Arch Pediatr Adolesc Med
|
2009
|
0.80
|
|
138
|
Incidence of severe pain in newly diagnosed ambulatory patients with stage IV cancer.
|
Pain Res Manag
|
2012
|
0.80
|
|
139
|
Talking with patients about dying.
|
N Engl J Med
|
2013
|
0.80
|
|
140
|
Assessing the quality of pain care in ambulatory patients with advanced stage cancer.
|
J Pain Symptom Manage
|
2012
|
0.80
|
|
141
|
Factors associated with pain among ambulatory patients with cancer with advanced disease at a comprehensive cancer center.
|
J Oncol Pract
|
2012
|
0.79
|
|
142
|
Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ.
|
Ann Surg Oncol
|
2014
|
0.78
|
|
143
|
A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer.
|
Cancer
|
2012
|
0.78
|
|
144
|
Disparities in oncologic surgery.
|
World J Surg
|
2008
|
0.78
|
|
145
|
Cancer and leukemia group B cancer control and health outcomes committee: origins and accomplishments.
|
Clin Cancer Res
|
2006
|
0.77
|
|
146
|
Adjuvant ovarian suppression versus chemotherapy for premenopausal, hormone-responsive breast cancer: quality of life and efficacy tradeoffs.
|
Breast Cancer Res Treat
|
2005
|
0.77
|
|
147
|
Continued use of trastuzumab beyond disease progression in the national comprehensive cancer network: should we practice ahead of the evidence?
|
Oncologist
|
2011
|
0.76
|
|
148
|
Re: personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.
|
J Natl Cancer Inst
|
2011
|
0.75
|